Numerous pharmacological research has been performed to search for helpful AD treatments, including disease‐modifying therapies targeting Aβ and tau, as well as symptomatic therapies aiming to improve cognitive, neuropsychiatric, and behavioral symptoms. The gene discussed is MAPT; the disease is Alzheimer disease.